Article
Quantification of Total and Mutant Huntingtin Protein Levels in Biospecimens Using a Novel alphaLISA Assay.
eNeuro - 1 Jan 2018
Baldo Barbara, Sajjad Muhammad Umar, Cheong Rachel Y, Bigarreau Julie, Vijayvargia Ravi, McLean Catriona, Perrier Anselme L, Seong Ihn Sik, Halliday Glenda, Petersén Åsa, Kirik Deniz
Abstract excerpt
The neurodegenerative Huntington's disease (HD) is caused by a polyglutamine (polyQ) amplification in the huntingtin protein (HTT). Currently there is no effective therapy available for HD; however, several efforts are directed to develop and optimize HTT-lowering methods to improve HD phenotypes. To validate these approaches, there is an immediate need for reliable, sensitive, and easily accessible methods to...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
